(MENAFN- GetNews)


"Global Digital Biomarkers Market"Digital Biomarkers Companies are BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene, PathAI, and others.

DelveInsight's Digital Biomarkers Market Insights Report offers comprehensive coverage of current and future market trends, competitive dynamics, growth drivers, barriers, and strategic developments across the sector.

The use of digital biomarkers is accelerating worldwide, driven by the rising prevalence of chronic diseases such as cardiovascular, neurological, and metabolic disorders. Aging populations-who are more prone to such conditions-are further boosting demand, while the growing adoption of wearable technologies and continuous innovation from market leaders is fueling market expansion at an unprecedented pace.

Download the Full Digital Biomarkers Market Outlook & Stay Ahead of 17% CAGR Growth – Global Digital Biomarkers Market

Key Digital Biomarkers Market Highlights

• North America is expected to lead the global digital biomarkers market throughout the forecast period.
• In 2024, physiological biomarkers accounted for the largest segment share.
• The market features prominent digital biomarker companies such as BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene Corporation, PathAI, and others.

Recent Strategic Collaborations in Digital Biomarkers

• June 2025: Agenus and Noetik partnered to develop AI-enabled predictive biomarkers for BOT/BAL using virtual cell biology models to personalize immunotherapy.
• March 2025: Lunit teamed up with the U.S. National Cancer Institute (NCI) to advance AI-driven digital biomarkers for tumor microenvironment and immune phenotyping in cancer research.
• March 2025: BostonGene initiated AI-based molecular profiling initiatives to explore colorectal cancer and multiple myeloma biomarkers through clinical trials.

Explore Strategic Opportunities with Leading Digital Biomarker Innovators - Access the Report Now - Digital Biomarkers Market Forecast

What Are Digital Biomarkers?

Digital biomarkers involve measurable physiological or behavioral data collected using digital devices such as smartphones, wearables, or biosensors. Unlike traditional lab-based biomarkers, they enable remote, real-time, and continuous monitoring of health indicators, including:

• Heart rate variability
• Sleep cycles
• Gait characteristics
• Voice tone
• Typing patterns

These technologies provide deeper visibility into disease progression, treatment response, and daily health patterns outside clinical environments. Their use is expanding across clinical trials, precision medicine, and chronic disease monitoring.

Tap into North America's Dominance - Get Regional Insights & Competitive Intelligence - Digital Biomarkers Competitive Landscape

Digital Biomarkers Market Insights & Regional Leadership

North America holds a dominant market position due to:

• High chronic disease burden
• A growing elderly population
• Broad use of wearables and connected health devices
• Continuous product innovation and timely regulatory support

These factors collectively reinforce the region's leadership in digital biomarker adoption and commercialization.

Key Digital Biomarkers Market Dynamics

The market's rapid progression is being shaped by:

• Increased integration of wearables and connected health platforms
• Growing emphasis on real-time health tracking and preventive care
• Adoption in clinical trials for adherence monitoring, patient stratification, and real-world evidence generation
• Supportive regulatory frameworks and evolving FDA guidance on digital health

However, challenges such as interoperability, data privacy, device standardization, and secure data management persist. To address these, companies are investing in AI-powered analytics, cloud platforms, and cross-industry partnerships.

Unlock AI-Driven Biomarker Trends & Partnerships - Request Your Market Brief Today - Digital Biomarkers Market Trends

Digital Biomarkers Future Outlook

Innovation in sensors, machine learning, virtual monitoring tools, and mobile health apps is expanding digital biomarker applications into:

• Mental health
• Oncology
• Neurology
• Autoimmune and metabolic diseases

Organizations that offer scalable, secure, interoperable technologies are projected to gain a strong competitive edge in this evolving landscape.

Digital Biomarkers Market Segmentation

Digital Biomarkers Market By Product Type:

• Wearable Devices
• Implantable Devices
• Software/Applications

Digital Biomarkers Market By Biomarker Type:

• Physiological
• Behavioral
• Biochemical

Digital Biomarkers Market By Indication:

• Neurological
• Cardiovascular
• Metabolic
• Others

Digital Biomarkers Market By Application:

• Diagnostic
• Monitoring
• Predictive

Digital Biomarkers Market By Region:

• North America Digital Biomarkers Market
• Europe Digital Biomarkers Market
• Asia-Pacific Digital Biomarkers Market
• Rest of World Digital Biomarkers Market

Discover Segment-Wise Growth across Wearables, Diagnostics & Predictive Biomarkers - Get the Full Analysis - Digital Biomarkers Market Size and Forecasts

Digital Biomarkers Market Overview at a Glance

• Study Period: 2022–2032
• CAGR: ~17%
• Forecasted Market Size (2032): ~USD 14 Billion
• Coverage: Global
• Key Companies: BioSensics, AliveCor, Eyenuk, Quibim, Huma, Evidation Health, Oura Health, Biobeat, Omada Health, F. Hoffmann-La Roche, Koneksa Health, Altoida, Empatica, VivoSense, IXICO, Proscia, Agenus, Lunit, BostonGene, PathAI, and others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

MENAFN16102025003238003268ID1110207676